Dr. Andrew Berchuck, MD

Dr. Berchuck practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Berchuck's NPI, 1154349181, was assigned on July 17, 2006. Dr. Berchuck graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 1980. Dr. Berchuck holds North Carolina license 31435.

Dr. Berchuck's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Berchuck's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. Dr. Berchuck is also affiliated with Cone Health Moses Cone Hospital. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Berchuck to 1 more hospital, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berchuck practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Berchuck's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Berchuck is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Berchuck is licensed in North Carolina.

CMS data shows 609 Medicare services from Dr. Berchuck across 8 procedure codes in 2024, for 159 Medicare patients. Medicare paid $43,118 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 159 Medicare patients who saw Dr. Berchuck in 2024. The largest group is 75 to 84, with 71 patients. 72% of them have high blood pressure, and 69% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berchuck's median patient age at 69, with 100% women.

In 2024, Dr. Berchuck wrote 89 Medicare Part D claims for 33 patients. 80% of them were for generic drugs. CMS names the drug for 47 of them, across 3 drugs with 11 or more claims each, at $532 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

Dr. Berchuck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Berchuck as offering telehealth. CMS counts 12 procedures of removal of the uterus by Dr. Berchuck, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 26 papers to Dr. Berchuck, published from 2015 to 2025. 2016 was the busiest year, with 13. The most frequent topics are Ovarian Neoplasms, Carcinoma, Ovarian Epithelial and Genetic Predisposition to Disease. Dr. Berchuck has published most often in Am J Epidemiol. Dr. Berchuck's most frequent co-authors are Joseph Leo Kelley, MD, Michael Ethan Carney, MD and Nadeem A. Siddiqui, MD.

CMS Open Payments shows 22 general payments to Dr. Berchuck from 12 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 93% of the total. Organon LLC paid the most, $12,046.

Dr. Berchuck graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 1980.